# Nephros Inc: Form 10-Q for the period ended Sep 30, 2014

- Company: [Nephros Inc](/companies/neph.md) (CIK 1196298)
- Form: 10-Q
- Filed: 2014-11-13
- Accepted by EDGAR: Nov 13, 2014, 16:30 ET
- Period: 2014-09-30
- Accession: 0001144204-14-067766
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1196298/000114420414067766/v391024_10q.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1196298/000114420414067766/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2014-09-30.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2014-07-01 to 2014-09-30 | $491.0k | us-gaap:SalesRevenueNet |
| Revenue | 9 months, 2014-01-01 to 2014-09-30 | $1.4m | us-gaap:SalesRevenueNet |
| Cost of revenue | 3 months, 2014-07-01 to 2014-09-30 | $175.0k | us-gaap:CostOfGoodsSold |
| Cost of revenue | 9 months, 2014-01-01 to 2014-09-30 | $423.0k | us-gaap:CostOfGoodsSold |
| Gross profit | 3 months, 2014-07-01 to 2014-09-30 | $316.0k | us-gaap:GrossProfit |
| Gross profit | 9 months, 2014-01-01 to 2014-09-30 | $983.0k | us-gaap:GrossProfit |
| Selling, general and administrative | 3 months, 2014-07-01 to 2014-09-30 | $765.0k | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months, 2014-01-01 to 2014-09-30 | $2.2m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months, 2014-07-01 to 2014-09-30 | −$681.0k | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months, 2014-01-01 to 2014-09-30 | −$1.9m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months, 2014-07-01 to 2014-09-30 | $65.0k | us-gaap:InterestExpense |
| Interest expense | 9 months, 2014-01-01 to 2014-09-30 | $277.0k | us-gaap:InterestExpense |
| Net income | 3 months, 2014-07-01 to 2014-09-30 | −$706.0k | us-gaap:NetIncomeLoss |
| Net income | 9 months, 2014-01-01 to 2014-09-30 | −$2.1m | us-gaap:NetIncomeLoss |
| Operating cash flow | 9 months, 2014-01-01 to 2014-09-30 | −$1.7m | us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations |
| Cash and equivalents | at 2014-09-30 | $1.0m | us-gaap:Cash |
| Current assets | at 2014-09-30 | $1.4m | us-gaap:AssetsCurrent |
| Total assets | at 2014-09-30 | $3.1m | us-gaap:Assets |
| Current liabilities | at 2014-09-30 | $3.1m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2014-09-30 | $3.5m | us-gaap:Liabilities |
| Shareholders' equity | at 2014-09-30 | −$386.0k | us-gaap:StockholdersEquity |

## Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/1196298/000114420414067766/v391024_10q.htm

Filed Nov 13, 2014.
Source: SEC EDGAR, the filing index for accession 0001144204-14-067766. Last ingested by Listed: Nov 13, 2026, 16:20 ET. No prices; not investment advice.
